← Back to Search

Device

Proxiscan device for Prostate Cancer

Phase < 1
Waitlist Available
Led By Benjamin Franc, MD
Research Sponsored by Radiological Associates of Sacramento Medical Group Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within on month of scan and corresponding mri
Awards & highlights

Study Summary

This is a small study to determine if probe, similar to an ultrasound probe, can detect prostate cancer more specifically than other imaging studies in patients with a positive prostate cancer biopsy.

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within on month of scan and corresponding mri
This trial's timeline: 3 weeks for screening, Varies for treatment, and within on month of scan and corresponding mri for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Detection of PSMA antibody (ProstaScint)uptake patterns measured by Proxiscan in comparison with anatomic biopsy reports, conventional SPECT and MRI scans within one month of Proxiscan

Trial Design

1Treatment groups
Active Control
Group I: No interventionActive Control1 Intervention
All consenting patients will be imaged with the Proxiscan and data compared with MRI, ProstaScint and biopsy data

Find a Location

Who is running the clinical trial?

Hybridyne Imaging TechnologiesUNKNOWN
Radiological Associates of Sacramento Medical Group Inc.Lead Sponsor
Benjamin Franc, MDPrincipal InvestigatorRadiological Associates of Sacramento Medical Group Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Prostate Cancer Imaging With Radioactive Tracer and Ultrasound Detector Compared to MRI and ProstaScint
2011. "Prostate Cancer Imaging With Radioactive Tracer and Ultrasound Detector Compared to MRI and ProstaScint". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01394042.
All > Aging > Prostate
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top